How do anticoagulants affect the progression of chronic thromboembolic pulmonary hypertension (CTEPH), and what outcomes are observed in treated patients?
Gaurav ChauhanContributor
How do anticoagulants influence the progression of chronic thromboembolic pulmonary hypertension (CTEPH)?
Share
Anticoagulants are essential in managing CTEPH as they prevent new clot formation and potentially reduce disease progression, leading to stabilized symptoms and improved survival rates.
Anticoagulant therapy in CTEPH patients primarily prevents further thromboembolic events, helping to mitigate disease progression and improve overall clinical outcomes.